CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


V-SARSWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug1724 P2Et (Caesalpinia spinosa extract) Wiki 1.00
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Clinical Trial of COVID-19 Therapeutic Vaccine Formulated as an Oral Pill

Safety and immunogenicity one-month study in healthy individuals administered once-daily pill of therapeutic vaccine made from heat-inactivated plasma from donors with COVID-19. Healthy, at least 20, volunteers will be monitored for signs of adverse events. Their PBMC will be collected at baseline and one month later to analyze which type of immune response vaccine has induced.

NCT04380532 Covid19 Biological: V-SARS

Primary Outcomes

Description: Routine laboratory complete blood cell count at pre- and post-treatment periods by automated CBC counter Routine laboratory complete blood count Routine clinical laboratory CBC parameters at pre- and post-treatment periods

Measure: Effect on CBC as per CTCAE v4.0

Time: 15 Days

Description: Routine clinical laboratory blood biochemistry parameters at pre- and post-treatment periods by automated biochemistry analyzer

Measure: Effect on biochemistry parameters as per CTCAE v4.0

Time: 15 Days

Secondary Outcomes

Description: Clinical well-being assessed by CTCAE v4.0

Measure: Lack of adverse events as per CTCAE v4.0

Time: 15 days


No related HPO nodes (Using clinical trials)